Life-sciences technology company plans Innovation Quarter facility
GeisterBio’s near-term commercialization initiative, SingleScan, is designed to improve the consistency and quantitative comparability of CT measurements, helping researchers and clinicians generate more reliable imaging data.
Full article text belongs to the original publisher. Moogle News shows the headline/summary and sends you to the source.
Read full story on publisher site →